ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Metagenomi Inc

Metagenomi Inc (MGX)

1.85
0.00
(0.00%)
At close: December 08 4:00PM
1.85
0.005
( 0.27% )
After Hours: 6:46PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.85
Bid
1.78
Ask
2.45
Volume
620,406
1.83 Day's Range 1.985
1.61 52 Week Range 12.74
Market Cap
Previous Close
1.85
Open
1.84
Last Trade
1
@
1.85
Last Trade Time
19:01:29
Financial Volume
$ 1,181,697
VWAP
1.9047
Average Volume (3m)
386,422
Shares Outstanding
37,423,917
Dividend Yield
-
PE Ratio
-1.01
Earnings Per Share (EPS)
-1.82
Revenue
44.76M
Net Profit
-68.26M

About Metagenomi Inc

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was $1.85. Over the last year, Metagenomi shares have traded in a share price range of $ 1.61 to $ 12.74.

Metagenomi currently has 37,423,917 shares outstanding. The market capitalization of Metagenomi is $69.23 million. Metagenomi has a price to earnings ratio (PE ratio) of -1.01.

MGX Latest News

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The Gross...

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX PR Newswire NEW YORK, Nov. 21, 2024 NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues...

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Nov. 14, 2024 NEW YORK, Nov. 14, 2024 /PRNewswire/ -- The Gross...

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

Initiating IND-enabling activities for MGX-001 development candidate (DC) in hemophilia A; Achieved durable Factor VIII activity levels over twelve months in nonhuman primate (NHP) study On track...

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Shareholders that lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/...

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm

Class Action Filed Against Metagenomi, Inc. (MGX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Nov. 7, 2024 NEW YORK, Nov. 7, 2024 /PRNewswire/ -- The Gross...

Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting

EMERYVILLE, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.17-8.415841584162.022.181.833584851.95472532CS
4-0.19-9.31372549022.042.341.615138611.90991424CS
12-0.84-31.22676579932.692.951.613864222.02929593CS
26-4.79-72.13855421696.646.91.612256342.35090725CS
52-8.4-81.951219512210.2512.741.612012544.70460012CS
156-8.4-81.951219512210.2512.741.612012544.70460012CS
260-8.4-81.951219512210.2512.741.612012544.70460012CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZEOZeo Energy Corporation
$ 2.43
(85.50%)
1.03M
MRMMEDIROM Healthcare Technologies Inc
$ 5.49
(80.00%)
1.63M
TLFTandy Leather Factory Inc
$ 5.14
(28.18%)
37.09k
WKSPWorksport Ltd
$ 0.984
(27.63%)
1.42M
FAASDigiAsia Corporation
$ 0.729
(24.32%)
165.33k
BIOABioAge Labs Inc
$ 6.6001
(-67.15%)
763.37k
LIFWMSP Recovery Inc
$ 2.73
(-15.74%)
925.81k
SMXSMX Security Matters Public Company
$ 0.42
(-14.29%)
4.05M
EEIQEpicQuest Education Group International Ltd
$ 0.8703
(-12.97%)
8.96k
ERNAEterna Therapeutics Inc
$ 0.35
(-12.48%)
227.92k
SMCISuper Micro Computer Inc
$ 47.85
(8.92%)
14.19M
RIMEAlgorhythm Holdings Inc
$ 0.0951
(3.37%)
10.52M
SVMHSRIVARU Holding Ltd
$ 0.0297
(1.37%)
7.62M
DRMADermata Therapeutics Inc
$ 1.4899
(3.47%)
6.86M
CRKNCrown Electrokinetics Corporation
$ 0.2649
(6.34%)
5.66M

Your Recent History

Delayed Upgrade Clock